EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Contrast‐enhanced harmonic endoscopic ultrasound (CH‐EUS) MASTER: A novel deep learning‐based system in pancreatic mass diagnosis

Anliu Tang iD, Li Tian, Kui Gao, Rui Liu, Shan Hu, Jinzhu Liu, Jiahao Xu, Tian Fu, Zinan Zhang, Wujun Wang, Long Zeng, Weiming Qu und 4 weitere

Cancer Medicine · 2023-04 · 12 (7) · 7962-7973

DOI: 10.1002/cam4.5578 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cancer Medicine, online erschienen am 06.01.2023. Verfasst von Anliu Tang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, China. Hauptthemen laut MEDLINE: Deep Learning, Pancreatic Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Distinguishing pancreatic cancer from nonneoplastic masses is critical and remains a clinical challenge. The study aims to construct a deep learning‐based artificial intelligence system to facilitate pancreatic mass diagnosis, and to guide EUS‐guided fine‐needle aspiration (EUS‐FNA) in real time.

Methods

This is a prospective study. The CH‐EUS MASTER system is composed of Model 1 (real‐time capture and segmentation) and Model 2 (benign and malignant identification). It was developed using deep convolutional neural networks and Random Forest algorithm. Patients with pancreatic masses undergoing CH‐EUS examinations followed by EUS‐FNA were recruited. All patients underwent CH‐EUS and were diagnosed both by endoscopists and CH‐EUS MASTER. After diagnosis, they were randomly assigned to undergo EUS‐FNA with or without CH‐EUS MASTER guidance.

Results

Compared with manual labeling by experts, the average overlap rate of Model 1 was 0.708. In the independent CH‐EUS video testing set, Model 2 generated an accuracy of 88.9% in identifying malignant tumors. In clinical trial, the accuracy, sensitivity, and specificity for diagnosing pancreatic masses by CH‐EUS MASTER were significantly better than that of endoscopists. The accuracy, sensitivity, specificity, positive predictive value, and negative predictive value were respectively 93.8%, 90.9%, 100%, 100%, and 83.3% by CH‐EUS MASTER guided EUS‐FNA, and were not significantly different compared to the control group. CH‐EUS MASTER‐guided EUS‐FNA significantly improved the first‐pass diagnostic yield.

Conclusion

CH‐EUS MASTER is a promising artificial intelligence system diagnosing malignant and benign pancreatic masses and may guide FNA in real time. Trial registration number: NCT04607720.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep LearningPancreatic NeoplasmsHumansArtificial IntelligenceEndoscopic Ultrasound-Guided Fine Needle AspirationProspective Studies

Stichwörter der Autor:innen

artificial intelligenceendoscopic ultrasound-guided fine-needle aspirationharmonic contrast-enhanced endoscopic ultrasoundpancreatic cancerpancreatitis

Autor:innen und Institutionen

  • Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Central South University, Changsha, China.
  • Wuhan EndoAngel Medical Technology Co., Ltd., Wuhan, China.
  • Department of Gastroenterology, Zhuzhou Central Hospital, Zhuzhou, China.
  • Department of Gastroenterology, The First Affiliated Hospital of University of South China, Hengyang, China.
  • Department of Gastroenterology, General Hospital of Ningxia Medical University, Ningxia, China.

ORCID-Profile: Anliu Tang

Zitieren

APA

Tang, A., Tian, L., Gao, K., Liu, R., Hu, S., Liu, J., Xu, J., Fu, T., Zhang, Z., Wang, W., Zeng, L., Qu, W., Dai, Y., Hou, R., Tang, S., & Wang, X. (2023). Contrast‐enhanced harmonic endoscopic ultrasound (CH‐EUS) MASTER: A novel deep learning‐based system in pancreatic mass diagnosis. Cancer Medicine, 12(7), 7962-7973. https://doi.org/10.1002/cam4.5578

Vancouver

Tang A, Tian L, Gao K, Liu R, Hu S, Liu J, et al. Contrast‐enhanced harmonic endoscopic ultrasound (CH‐EUS) MASTER: A novel deep learning‐based system in pancreatic mass diagnosis. Cancer Medicine. 2023;12(7):7962-7973. doi:10.1002/cam4.5578

BibTeX
@article{Tang2023,
  author = {Tang, Anliu and Tian, Li and Gao, Kui and Liu, Rui and Hu, Shan and Liu, Jinzhu and Xu, Jiahao and Fu, Tian and Zhang, Zinan and Wang, Wujun and Zeng, Long and Qu, Weiming and Dai, Yong and Hou, Ruirui and Tang, Shoujiang and Wang, Xiaoyan},
  title = {Contrast‐enhanced harmonic endoscopic ultrasound (CH‐EUS) MASTER: A novel deep learning‐based system in pancreatic mass diagnosis},
  journal = {Cancer Medicine},
  year = {2023},
  volume = {12},
  number = {7},
  pages = {7962--7973},
  doi = {10.1002/cam4.5578}
}
Kostenlos starten →